Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02019277
Brief Title: A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (SAPPHIRE)

First Submitted : December 18, 2013
First Submitted that Met QC Criteria : December 23, 2013
First Posted : December 24, 2013 (Estimate)

Results First Submitted : October 10, 2017
Results First Submitted that Met QC Criteria : October 10, 2017
Results First Posted : July 23, 2018

Last Update Submitted that Met QC Criteria : September 11, 2018
Last Update Posted : September 13, 2018